% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Fischer:278069,
author = {Fischer, Larissa and Adams, Jenna N and Molloy, Eóin N.
and Vockert, Niklas and Tremblay-Mercier, Jennifer and Remz,
Jordana and Pichet Binette, Alexa and Villeneuve, Sylvia and
Maass, Anne},
collaboration = {Group, PREVENT-AD Research},
title = {{D}ifferential effects of aging, {A}lzheimer's pathology,
and {APOE}4 on longitudinal functional connectivity and
episodic memory in older adults.},
journal = {Alzheimer's research $\&$ therapy},
volume = {17},
number = {1},
issn = {1758-9193},
address = {London},
publisher = {BioMed Central},
reportid = {DZNE-2025-00560},
pages = {91},
year = {2025},
abstract = {Both aging and Alzheimer's disease (AD) affect brain
networks, with early disruptions occurring in regions
involved in episodic memory. Few studies have, however,
focused on distinguishing region-specific effects of
AD-biomarker negative 'normal' aging and early amyloid- and
tau pathology on functional connectivity. Further,
longitudinal studies combining imaging, biomarkers, and
cognition are rare.We assessed resting-state functional
connectivity (rsFC) strength and graph measures in the
episodic memory network including the medial temporal lobe
(MTL), posteromedial cortex (PMC), and medial prefrontal
cortex alongside cognition over two years. For this
preregistered study, we included 100 older adults who were
amyloid- and tau-negative using CSF and PET measurements to
investigate 'normal' aging, and 70 older adults who had
longitudinal CSF data available to investigate functional
changes related to early AD pathology. All participants were
cognitively unimpaired older adults from the PREVENT-AD
cohort. We used region of interest (ROI)-to-ROI bivariate
correlations, graph analysis, and multiple regression
models.In the amyloid- and tau-negative sample, rsFC
strength within PMC, between parahippocampal cortex and
inferomedial precuneus, and between posterior hippocampus
and inferomedial precuneus decreased over time.
Additionally, we observed a longitudinal decrease in global
efficiency. Further, there was a steeper longitudinal
decrease in rsFC and global efficiency with higher baseline
age particularly of parahippocampal-gyrus regions. Further,
lower rsFC strength within PMC was associated with poorer
longitudinal episodic memory performance. In the sample with
available CSF data, a steeper increase in rsFC between
anterior hippocampus and superior precuneus was related to
higher baseline AD pathology. Higher MTL-PMC rsFC strength
was differentially associated with episodic memory
trajectories depending on APOE4 genotype.Our findings
suggest differential effects of aging and AD pathology.
Hypoconnectivity within PMC was related to aging and
cognitive decline. MTL-PMC hyperconnectivity was related to
early AD pathology and cognitive decline in APOE4 carriers.
Future studies should investigate more diverse samples,
nonetheless, our approach allowed us to identify
longitudinal functional changes related to aging and early
AD pathology, enhancing cross-sectional research.
Hyperconnectivity has been proposed as a mechanism related
to early AD pathology before, we now contribute specific
functional connections to focus on in future research.},
keywords = {Humans / Memory, Episodic / Male / Female / Aged /
Alzheimer Disease: pathology / Alzheimer Disease: diagnostic
imaging / Alzheimer Disease: genetics / Alzheimer Disease:
physiopathology / Alzheimer Disease: psychology / Aging:
pathology / Aging: psychology / Apolipoprotein E4: genetics
/ Longitudinal Studies / Positron-Emission Tomography /
Brain: diagnostic imaging / Brain: pathology / Brain:
physiopathology / Magnetic Resonance Imaging / Aged, 80 and
over / Middle Aged / Neural Pathways: physiopathology /
Neural Pathways: diagnostic imaging / tau Proteins:
cerebrospinal fluid / APOE (Other) / Aging (Other) /
Alzheimer’s disease (Other) / Episodic memory (Other) /
FMRI (Other) / Functional connectivity (Other) /
Apolipoprotein E4 (NLM Chemicals) / tau Proteins (NLM
Chemicals)},
cin = {AG Maaß},
ddc = {610},
cid = {I:(DE-2719)1311001},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40281595},
doi = {10.1186/s13195-025-01742-6},
url = {https://pub.dzne.de/record/278069},
}